Comparison results
| Results: Differences General | ✘Atypical mycobacterial infections | ✘Abuse of phenylpropanolamine | |||||||
| Related research | Analogs | Analogs | |||||||
| |||||||||
| Distinctive symptoms | |||||||||
| Register, to see more distinctive signs of diseases and studies | 51% | — | |||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||
| cervical syndrome | 44% | — | |||||||
| poly-drug addiction and polytoxicomania | — | 48% | |||||||
| madaroz | 44% | — | |||||||
| propulsion | — | 47% | |||||||
| lymphadenitis | 42% | — | |||||||
| addiction | — | 46% | |||||||
| skin problems | 41% | — | |||||||
| fussiness | — | 46% | |||||||
| impaired lung function | 39% | — | |||||||
| aching all over the body | — | 40% | |||||||
| bursitis of the elbow joint | 39% | — | |||||||
| euphoria | — | 38% | |||||||
| history of surgery | 39% | — | |||||||
| head severe | — | 37% | |||||||
| leprosy | 38% | — | |||||||
| feeling of heaviness in the head | — | 37% | |||||||
| infected wounds | 36% | — | |||||||
| takes antidepressants | — | 35% | |||||||
| ulnar nerve neuropathy | 36% | — | |||||||
| encephalopathy | — | 32% | |||||||
| wound | 35% | — | |||||||
| cough | — | 30% | |||||||
| lymphadenitis in children | 34% | — | |||||||
| general weakness | — | 30% | |||||||
| cubital canal syndrome | 34% | — | |||||||
| family man | — | 29% | |||||||
| lymph node damage | 34% | — | |||||||
| pain chest | — | 29% | |||||||
| papules | 31% | — | |||||||
| aching | — | 28% | |||||||
| immunodeficiency | 30% | — | |||||||
| calcium | — | 28% | |||||||
| reaction to manta rays | 30% | — | |||||||
| neurological disorders | 20% | 47% | |||||||
| medicinal arthropathy | 28% | — | |||||||
| headaches | — | 27% | |||||||
| bursitis | 28% | — | |||||||
| damage to the nervous system | — | 26% | |||||||
| pain in the lymph nodes | 28% | — | |||||||
| stage of recovery | — | 26% | |||||||
| effects of hormone | 27% | — | |||||||
| recovery period | — | 26% | |||||||
| consequences of infection | 27% | — | |||||||
| heart dysfunction | — | 26% | |||||||
| fluid in the joints | 27% | — | |||||||
| increased | — | 23% | |||||||
| chronic granulomatous disease | 26% | — | |||||||
| ARVI | 24% | 32% | |||||||
| lower respiratory tract infections | 26% | — | |||||||
| drug disease | 19% | 25% | |||||||
| n | 23% | — | |||||||
| tuberculosis | 23% | — | |||||||
| does not tolerate pain | 22% | — | |||||||
| traumatic illness | 22% | — | |||||||
| arthritis | 22% | — | |||||||
| bacteremia | 22% | — | |||||||
| worse during day | 21% | — | |||||||
| joint diseases | 21% | — | |||||||
| hypertension | 20% | — | |||||||
| necrosis | 20% | — | |||||||
| consequences of taking medications | 18% | — | |||||||
Instructions
Video
|